Dendron-Like Lipid Compounds for Targeted Nanoparticle Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for more diverse and effective drug delivery systems, particularly for insoluble small molecules, proteins, and nucleic acid drugs, to enhance solubility, protect against degradation, and reduce immune activation and side effects.
Innovation Solution
Development of dendron-like lipid compounds with specific structures for forming liposomes and lipid nanoparticles that can target and deliver active substances like small molecule compounds, siRNA, mRNA, or proteins to cells, tissues, or organs, using a combination of dendron-like heads, lipophilic long-chain tails, and linkers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If conventional nano-delivery systems are used, then drug delivery capability is provided, but diversity of lipid compound types is limited
Solution Approach 1:
The dendron-like lipid compound is divided into distinct functional segments: a dendron-like head group (providing branching structure and functional groups), a linker region, and a lipophilic tail. This segmentation allows independent optimization of each component's properties while maintaining overall molecular function, thereby increasing diversity without proportionally increasing complexity.
Solution Approach 2:
Different regions of the lipid molecule are assigned specific local properties: the head group contains polar/charged functional groups for solubility and targeting, the linker provides flexibility and spacing, and the tail provides membrane integration capability. This local differentiation enables diverse functionality from a unified molecular architecture.
2Reliability
If dendron-like lipid compounds with complex structures are developed, then targeted delivery capability is improved, but manufacturing complexity increases
Solution Approach 1:
The dendron-like head group and linker are synthesized and purified as a pre-assembled unit before final coupling with the lipophilic tail. This preliminary action allows optimization of the polar region's functionality without requiring complex multi-step synthesis of the entire molecule, thereby improving targeted delivery capability while managing manufacturing complexity.
Solution Approach 2:
The linker region serves as an intermediary component that connects the dendron-like head group to the lipophilic tail through modular coupling reactions. This intermediary approach allows independent synthesis and optimization of each component, facilitating easier manufacturing while maintaining the reliability of targeted delivery through the complete molecular structure.
3Manufacturing precision
If liposomes are formulated with dendron-like lipid compounds, then particle size uniformity is achieved, but formulation complexity increases
Solution Approach 1:
The dendron-like lipid compound's molecular parameters (branching degree, functional group types, chain length) are systematically varied to optimize liposome formation and stability. These parameter changes enable precise control over particle size distribution and surface properties, achieving manufacturing precision while the modular nature of the changes keeps formulation complexity manageable.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The novel dendron-like lipid compounds provide targeted delivery with uniform particle size distribution, low cytotoxicity, and the ability to protect and deliver active substances effectively, enhancing bioavailability and reducing side effects.
Implementation Method 1
Lipid nanoparticles (LNP) can not only protect drug molecules from degradation in vivo
Implementation Method 2
LNP can promote cellular uptake and specific tissue targeting
Data Source
AI summary
The present disclosure relates to a dendron-like lipid compound, a liposome, a lipid complex, and a lipid nanoparticle and a use thereof. The dendron-like lipid compound is selected from any one of structures of formulas I-III. The present disclosure relates to a series of dendron-like lipid compounds of novel structures; and liposomes prepared from the lipid compounds have uniform particle size distribution, carry negative charges on the surfaces, and have low cytotoxicity. The lipid nanoparticle can specifically target and deliver active substances to cells, tissues or organs, thereby realizing targeted delivery of the active substances.